SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 10, 2026

INM

InMed Pharmaceuticals Inc.
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago
Insider cluster: 2 insiders, $189K total
Actionable Insight ▲ Bullish

The magnitude of this cluster buy (4.7% of market cap from two 10% owners) is a strong bullish signal at a micro-cap with no analyst support. Monitor for upcoming press releases, pipeline updates, or financing announcements, the insiders may be positioning ahead of material news. The stock's low liquidity means even small volume could amplify moves.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.58
T+0 close · Jun 10, 2026 · via day close
Latest settled
−12.66%
T+60 · $1.38
Vs SPY
−17.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $1.58entry
  2. T+1 · 5mo ago −4.43%α −4.97% · $1.51
  3. T+5 · 5mo ago −5.70%α −6.13% · $1.49
  4. T+20 · 4mo ago +5.06%α +3.17% · $1.66
  5. T+60 · 2mo ago −12.66%α −17.05% · $1.38
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two 10% owners (Vivo Opportunity, LLC and ADAR1 Capital Management, LLC) purchased a combined $189K of INM stock in an 8-day window, representing ~4.7% of the company's $4M market cap. This is a highly material cluster buy from sophisticated investors at a micro-cap pharma with no analyst bullish coverage, suggesting conviction ahead of a potential catalyst.

Key Financial Metrics

Direction
buying
Total Value
$189.0K
Insiders
2

Key Facts

  • Two 10% owners bought $189K total in open-market purchases over 8 days (May 13–20, 2026).
  • Total buy value equals ~4.7% of INM's $4M market cap, far exceeding the 2% materiality threshold.
  • Vivo Opportunity, LLC bought 51.1K shares at $1.56 ($80K) on May 20.
  • ADAR1 Capital Management, LLC bought 68.6K shares at $1.60 ($110K) on May 19.
  • INM has zero analyst buy ratings (3 Hold, 5 Sell/Strong Sell) and a $4M market cap.

Financial Impact

$189K in insider purchases = 4.7% of $4M market cap

insider ownershipmarket cap

Risk Factors

  • Micro-cap pharma with $4M market cap is highly speculative and illiquid.
  • No analyst bullish coverage and 5 sell/strong sell ratings indicate fundamental challenges.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INM-1781140524722

US Market Status

Market Closed · Opens in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026